We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Ultrathin Metasurface Could Bring Quantitative Phase Imaging to Portable Devices

By LabMedica International staff writers
Posted on 18 Aug 2026

Point-of-care imaging often depends on bulky optical systems that have difficulty visualizing nearly transparent cells and tissues without staining. More...

These limitations can slow diagnosis and restrict use at the bedside or in resource-limited settings. Although phase-based methods can reveal important morphological details, conventional systems often trade accuracy for speed and compactness. Researchers have now developed an ultrathin metasurface approach designed to capture quantitative phase information on smaller sensors, supporting more compact clinical imaging devices.

Researchers at the Australian Research Council Centre of Excellence for Transformative Meta-Optical Systems (TMOS), working across RMIT University and The University of Melbourne, have created a metasurface that supports quantitative phase microscopy (QPM). The device images microscopic objects that are nearly invisible to conventional intensity-based optics. It is designed to enable compact, field-deployable imaging for clinical and research settings.

The metasurface is “nonlocal,” meaning it processes the entire image rather than redirecting individual rays like a lens. Because it can sit directly in front of the sample, it reduces space and alignment demands. It integrates multiple nanostructured elements onto a single ultrathin surface to deliver phase-contrast information with minimal hardware movement.

Quantitative phase microscopy (QPM) requires phase-gradient measurements along two perpendicular directions. Conventional approaches typically obtain these measurements by rotating optical elements or swapping components, adding time and complexity to the imaging workflow. The new design integrates two sets of wavelength-selective nanostructures onto a single surface, allowing users to switch between orthogonal measurements simply by changing the illumination wavelength. The researchers also incorporated differential phase contrast to reduce noise and improve reconstructed phase maps.

Published in Nanophotonics on July 1, 2026, the approach is intended to simplify imaging workflows for conditions in which cell shape and growth patterns are clinically relevant, including sickle cell disease, cancer, and neurodegenerative disorders. The researchers note that near-term challenges include the cost of supporting hardware and fabrication, as well as the need for precisely tuned dual-wavelength illumination. They are also exploring integration with commercial microscopes using an infrared light-emitting diode.

Related Links
TMOS


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Gold Member
Aspiration System
VACUSAFE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The approach uses in-house pathology tests and streamlined access to specialists to shorten the diagnostic pathway for children with immune conditions. (Image Credit: iStock)

Streamlined Genetic Testing Speeds Pediatric Immune Disorder Diagnosis

Children with genetic immune conditions can develop life-threatening illness, unusual infections, or autoimmune problems before the underlying cause is identified. More than 500 of these rare disorders... Read more

Immunology

view channel
Image: Acute myeloid leukemia is the first of several disease areas the collaborators plan to pursue together as part of efforts to advance precision diagnostics (Image Credit: Adobe Stock)

Immune Profiling Initiative Aims to Improve Bone Marrow Analysis in Leukemia

Acute myeloid leukemia (AML) is an aggressive blood cancer in which assessing disease burden after therapy can help guide clinical evaluation. Patients with measurable residual disease (MRD) after treatment... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.